HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride.

Abstract
To establish the clinical efficacy of a single oral dose of pirmenol, we evaluated electrophysiologic and hemodynamic effects simultaneously after drug administration, performing electrophysiologic testing in 20 patients with ECG-documented paroxysmal supraventricular tachycardia (PSVT) before and after a single oral 200-mg dose of pirmenol. Hemodynamic measurements were made with a Swan-Ganz catheter in the first 10 consecutive patients. In a different series of patients, we administered a single 200-mg oral dose of pirmenol to evaluate its acute termination effect in 7 patients with PSVT and 9 with paroxysmal atrial fibrillation. Pirmenol prolonged the refractory period of the retrograde conduction system in patients with or without an accessory pathway, and supraventricular tachycardia was no longer inducible at 60 min in 11 patients [8 of 11 with atrioventricular (AV) reentrant tachycardia and 3 of 5 with AV nodal reentrant tachycardia]. Pirmenol increased the heart rate (p < 0.01) and total systemic resistance (p < 0.05), and reduced the stroke volume index (p < 0.01), all significantly. The plasma concentration of pirmenol at 1 h after administration was 0.75 +/- 0.48 microgram/ml. A single oral dose of pirmenol during tachyarrhythmia successfully restored sinus rhythm in 4 of 7 (57%) patients with PSVT and 4 of 9 (44%) patients with paroxysmal atrial fibrillation. A single oral dose of pirmenol was well tolerated as episodic treatment in patients with supraventricular tachyarrhythmias.
AuthorsH Atarashi, A Kuruma, T Ino, Y Hirayama, H Saitoh, H Hayakawa
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 27 Issue 4 Pg. 556-62 (Apr 1996) ISSN: 0160-2446 [Print] United States
PMID8847873 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Piperidines
  • pirmenol
Topics
  • Administration, Oral
  • Adult
  • Anti-Arrhythmia Agents (pharmacokinetics, therapeutic use)
  • Atrial Fibrillation (drug therapy)
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Piperidines (blood, pharmacokinetics, therapeutic use)
  • Tachycardia, Atrioventricular Nodal Reentry (drug therapy)
  • Tachycardia, Supraventricular (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: